CME Group (CME) PT Lowered to $214.00 at Deutsche Bank

CME Group (NASDAQ:CME) had its target price lowered by stock analysts at Deutsche Bank from $220.00 to $214.00 in a report issued on Friday. The firm currently has a “buy” rating on the financial services provider’s stock. Deutsche Bank’s price target would suggest a potential upside of 26.20% from the stock’s previous close.

Several other analysts have also recently commented on the company. BidaskClub cut CME Group from a “hold” rating to a “sell” rating in a report on Thursday. Citigroup set a $205.00 target price on CME Group and gave the stock a “buy” rating in a report on Friday, February 15th. JPMorgan Chase & Co. assumed coverage on CME Group in a report on Friday, February 15th. They issued an “underweight” rating and a $164.00 price target on the stock. Sanford C. Bernstein reiterated an “outperform” rating and issued a $210.00 price target on shares of CME Group in a report on Friday, February 15th. Finally, Bank of America reiterated a “neutral” rating and issued a $191.00 price target (down previously from $200.00) on shares of CME Group in a report on Friday, January 11th. They noted that the move was a valuation call. Two equities research analysts have rated the stock with a sell rating, eight have assigned a hold rating and seven have assigned a buy rating to the company. The company has an average rating of “Hold” and a consensus target price of $194.00.

CME Group stock traded up $1.14 during mid-day trading on Friday, hitting $169.58. 1,195,550 shares of the company were exchanged, compared to its average volume of 1,859,918. The company has a debt-to-equity ratio of 0.15, a current ratio of 1.01 and a quick ratio of 1.01. CME Group has a 1-year low of $153.90 and a 1-year high of $197.08. The firm has a market capitalization of $60.12 billion, a P/E ratio of 24.86, a P/E/G ratio of 2.15 and a beta of 0.31.

CME Group (NASDAQ:CME) last announced its earnings results on Thursday, February 14th. The financial services provider reported $1.77 EPS for the quarter, topping the consensus estimate of $1.75 by $0.02. The company had revenue of $1.24 billion for the quarter, compared to analysts’ expectations of $1.22 billion. CME Group had a return on equity of 9.85% and a net margin of 45.53%. The business’s revenue for the quarter was up 37.4% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.12 earnings per share. On average, equities research analysts predict that CME Group will post 7.07 EPS for the current fiscal year.

In other CME Group news, CFO John W. Pietrowicz sold 17,960 shares of the stock in a transaction dated Wednesday, January 2nd. The stock was sold at an average price of $186.92, for a total value of $3,357,083.20. Following the transaction, the chief financial officer now owns 44,780 shares of the company’s stock, valued at $8,370,277.60. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, COO Julie Holzrichter sold 4,362 shares of the stock in a transaction dated Friday, March 1st. The shares were sold at an average price of $182.45, for a total value of $795,846.90. Following the completion of the transaction, the chief operating officer now directly owns 41,265 shares in the company, valued at approximately $7,528,799.25. The disclosure for this sale can be found here. Insiders sold 32,609 shares of company stock worth $5,984,391 in the last three months. Insiders own 0.43% of the company’s stock.

A number of large investors have recently added to or reduced their stakes in CME. Peregrine Capital Management LLC raised its position in shares of CME Group by 2.5% during the fourth quarter. Peregrine Capital Management LLC now owns 92,984 shares of the financial services provider’s stock worth $17,492,000 after purchasing an additional 2,267 shares during the period. Chartwell Investment Partners LLC raised its position in shares of CME Group by 60.3% during the third quarter. Chartwell Investment Partners LLC now owns 39,284 shares of the financial services provider’s stock worth $6,687,000 after purchasing an additional 14,770 shares during the period. Legacy Bridge LLC acquired a new stake in shares of CME Group during the fourth quarter worth about $818,000. Swarthmore Group Inc. acquired a new stake in shares of CME Group during the fourth quarter worth about $8,061,000. Finally, Fox Run Management L.L.C. acquired a new stake in shares of CME Group during the fourth quarter worth about $250,000. 88.49% of the stock is currently owned by hedge funds and other institutional investors.

About CME Group

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products, and metals.

Featured Article: Lock-Up Period Expiration

Analyst Recommendations for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply